We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Forbion

News List

Lonza, Forbion and BioGeneration Ventures Extend Collaboration contractpharma
January 18, 2022
To add development and manufacturing services of small molecules.
Forbion’s Portfolio Company, Prexton Therapeutics Acquired by Lundbeck for up to EUR 905 million (US biospace
March 19, 2018
Forbion, today announces that H. Lundbeck A/S (Lundbeck) has acquired Forbion’s portfolio company Prexton Therapeutics B.V. (Prexton) for a total consideration of EUR 905 million (USD 1.1 billion).
Forbion Leads $19 Million Series B Financing of Escalier Biosciences to Advance its Topical and Syst biospace
March 14, 2018
Forbion, today announced that it led the $19 million Series B financing of Escalier Biosciences BV, a privately held biopharmaceutical company based in Nijmegen, The Netherlands.